Innovation with Integrity

Bruker Investor Relations

Company Overview

About Bruker

With nearly $2 billion in revenues and more than 6,000 employees worldwide, Bruker Corporation (NASDAQ: BRKR) is a global manufacturer of high-end analytical instruments used within the academic & government, pharma/biotech, clinical diagnostic, and industrial markets. The Company operates in the life science tools & diagnostics industry and has developed a strong brand for innovation and quality. Some of Bruker’s products include: magnetic technologies, spectroscopy and spectrometers, atomic force microscopy, diagnostic products and X-ray technologies. Many of these products are used to study the physical structure and biological characteristics of molecules and atoms. With more than 80 percent of its revenues generated from outside of the United States, Bruker serves a large and global customer base and has operations throughout the world.

Download our Bruker Product Overview.


In 2013, Bruker changed its operational structure to consolidate 10 operating divisions into three new Groups: Bruker BioSpin, Bruker CALID, and Bruker Materials. These Groups combined with the Bruker Energy & Supercon Technologies comprise the operating entities of the company today. To learn more about Bruker’s management team, please click here.


Bruker was founded in Karlsruhe, Germany in 1961 by Günther Laukien and the company soon became a pioneer in Nuclear Magnetic Resonance (NMR) Spectroscopy. The Company grew substantially in size and scale over the next four decades and expanded its reach into new technologies and markets. Beginning in the year 2000, several of the Bruker operating entities went public, including Bruker Daltonics, Bruker AXS and Bruker Optics. In 2008, all Bruker entities, including the addition of the original Bruker BioSpin Group, were combined to form the company as it exists today. Today, the Laukien family still owns approximately 34% of Bruker’s common shares. To learn more about Bruker’s history, please click here.


Bruker offers a broad portfolio of scientific instrumentation products. The Company’s market and technology leading products are driving and facilitating many key application areas such as life science research, pharmaceutical analysis, applied analytical chemistry applications, materials research and nanotechnology, clinical research, molecular diagnostics and homeland defense. Please click here to learn more about Bruker’s products: Bruker Product Overview

BRKR (Common Stock)

Stock Quote: NASD

Price $28.93

Change -0.09 (-0.31%)

07/13/18 04:00 PM Pricing delayed 20 minutes

Investor Contact

Miroslava Minkova
Head of Investor Relations
Bruker Corporation
P: +1 978 663 3660 x1479

Search Investor Relations